Clinical trial
Remdesivir in COVID-19 Treatment: A Randomised Trial
NCT04345419 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Remdesivir in COVID-19 Treatment: A Randomised Trial
- Lead sponsor
- Tanta University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 16, 2020
- Completion date
- December 1, 2020
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid